Literature DB >> 29295844

Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration.

Veronica Caraffini1, Bianca Perfler1, Johannes Lorenz Berg1, Barbara Uhl1, Silvia Schauer2, Karl Kashofer2, Nassim Ghaffari-Tabrizi-Wizsy3, Herbert Strobl3, Albert Wölfler1, Gerald Hoefler2, Heinz Sill1, Armin Zebisch1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29295844      PMCID： PMC5824335          DOI： 10.1182/blood-2017-09-804906

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  25 in total

Review 1.  State of the art in myeloid sarcoma.

Authors:  J M Klco; J S Welch; T T Nguyen; M Y Hurley; F H Kreisel; A Hassan; A C Lind; J L Frater
Journal:  Int J Lab Hematol       Date:  2011-08-24       Impact factor: 2.877

Review 2.  Is acute myeloid leukemia a liquid tumor?

Authors:  Maro Ohanian; Stefan Faderl; Farhad Ravandi; Naveen Pemmaraju; Guillermo Garcia-Manero; Jorge Cortes; Zeev Estrov
Journal:  Int J Cancer       Date:  2013-02-04       Impact factor: 7.396

Review 3.  RKIP: much more than Raf kinase inhibitory protein.

Authors:  Fahd Al-Mulla; Milad S Bitar; Zainab Taqi; Kam C Yeung
Journal:  J Cell Physiol       Date:  2013-08       Impact factor: 6.384

Review 4.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

5.  Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations.

Authors:  A Zebisch; M Haller; K Hiden; T Goebel; G Hoefler; J Troppmair; H Sill
Journal:  Leukemia       Date:  2009-04-09       Impact factor: 11.528

6.  Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.

Authors:  Christian Langer; Guido Marcucci; Kelsi B Holland; Michael D Radmacher; Kati Maharry; Peter Paschka; Susan P Whitman; Krzysztof Mrózek; Claudia D Baldus; Ravi Vij; Bayard L Powell; Andrew J Carroll; Jonathan E Kolitz; Michael A Caligiuri; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

Review 7.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

8.  DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1.

Authors:  Jie Xu; Wu Zhang; Xiao-Jing Yan; Xue-Qiu Lin; Wei Li; Jian-Qing Mi; Jun-Min Li; Jiang Zhu; Zhu Chen; Sai-Juan Chen
Journal:  J Hematol Oncol       Date:  2016-10-10       Impact factor: 17.388

9.  Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.

Authors:  Stefan Hatzl; Olivia Geiger; Maja Kim Kuepper; Veronica Caraffini; Till Seime; Tobias Furlan; Erika Nussbaumer; Rotraud Wieser; Martin Pichler; Marcel Scheideler; Katarzyna Nowek; Mojca Jongen-Lavrencic; Franz Quehenberger; Albert Wölfler; Jakob Troppmair; Heinz Sill; Armin Zebisch
Journal:  Cancer Res       Date:  2016-04-15       Impact factor: 12.701

10.  Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing.

Authors:  Karl Kashofer; Max Gornicec; Karin Lind; Veronica Caraffini; Silvia Schauer; Christine Beham-Schmid; Albert Wölfler; Gerald Hoefler; Heinz Sill; Armin Zebisch
Journal:  Leuk Lymphoma       Date:  2017-06-20
View more
  5 in total

1.  Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer.

Authors:  Yaqing Li; Zhenfeng Tian; Ying Tan; Guoda Lian; Shangxiang Chen; Shaojie Chen; Jiajia Li; Xuanna Li; Kaihong Huang; Yinting Chen
Journal:  Mol Cancer       Date:  2020-06-24       Impact factor: 27.401

2.  Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis.

Authors:  Veronica Caraffini; Olivia Geiger; Angelika Rosenberger; Stefan Hatzl; Bianca Perfler; Johannes L Berg; Clarice Lim; Herbert Strobl; Karl Kashofer; Silvia Schauer; Christine Beham-Schmid; Gerald Hoefler; Klaus Geissler; Franz Quehenberger; Walter Kolch; Dimitris Athineos; Karen Blyth; Albert Wölfler; Heinz Sill; Armin Zebisch
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

3.  Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.

Authors:  Johannes Lorenz Berg; Bianca Perfler; Stefan Hatzl; Marie-Christina Mayer; Sonja Wurm; Barbara Uhl; Andreas Reinisch; Ingeborg Klymiuk; Sascha Tierling; Gudrun Pregartner; Gerhard Bachmaier; Andrea Berghold; Klaus Geissler; Martin Pichler; Gerald Hoefler; Herbert Strobl; Albert Wölfler; Heinz Sill; Armin Zebisch
Journal:  Clin Epigenetics       Date:  2021-01-06       Impact factor: 6.551

Review 4.  Targeting Raf Kinase Inhibitory Protein Regulation and Function.

Authors:  Ali Ekrem Yesilkanal; Marsha Rich Rosner
Journal:  Cancers (Basel)       Date:  2018-09-04       Impact factor: 6.639

Review 5.  RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis.

Authors:  Armin Zebisch; Veronica Caraffini; Heinz Sill
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.